CL2020003015A1 - Conversión a escala preparativa de goniautoxinas en neosaxitoxina - Google Patents

Conversión a escala preparativa de goniautoxinas en neosaxitoxina

Info

Publication number
CL2020003015A1
CL2020003015A1 CL2020003015A CL2020003015A CL2020003015A1 CL 2020003015 A1 CL2020003015 A1 CL 2020003015A1 CL 2020003015 A CL2020003015 A CL 2020003015A CL 2020003015 A CL2020003015 A CL 2020003015A CL 2020003015 A1 CL2020003015 A1 CL 2020003015A1
Authority
CL
Chile
Prior art keywords
neosaxitoxin
goniautoxins
preparative
scale conversion
goniautoxin
Prior art date
Application number
CL2020003015A
Other languages
English (en)
Inventor
Andrew Ian Selwood
Ginkel Roelof Van
Craig Alan Waugh
Original Assignee
The Cawthron Inst Trust Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Cawthron Inst Trust Board filed Critical The Cawthron Inst Trust Board
Publication of CL2020003015A1 publication Critical patent/CL2020003015A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12Unicellular algae; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12Unicellular algae; Culture media therefor
    • C12N1/125Unicellular algae isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00Bioreactors or fermenters specially adapted for specific uses
    • C12M21/02Photobioreactors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/14Bags
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/22Transparent or translucent parts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/06Nozzles; Sprayers; Spargers; Diffusers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/26Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02Separating microorganisms from the culture medium; Concentration of biomass
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/89Algae ; Processes using algae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describe un método para preparar neosaxitoxina en cantidades de una pureza suficiente para permitir que el compuesto se use como ingrediente farmacéutico activo (API). El método incluye la desulfonación reductora de una mezcla no resuelta de goniautoxina 1 (GTX1) y goniautoxina 4 (GTX4), mediante el uso de un ditiol (como DTT o DTBA) en una solución donde el pH está en el rango de 7,4 a 7,6. El producto de reacción se purifica usando un sorbente de intercambio catiónico débil a base de sílice para separar la neosaxitoxina del ditiol.
CL2020003015A 2018-09-21 2020-11-19 Conversión a escala preparativa de goniautoxinas en neosaxitoxina CL2020003015A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2018/057274 WO2020058750A1 (en) 2018-09-21 2018-09-21 A semisynthetic method of preparing neosaxitoxin

Publications (1)

Publication Number Publication Date
CL2020003015A1 true CL2020003015A1 (es) 2021-06-25

Family

ID=69888393

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020003015A CL2020003015A1 (es) 2018-09-21 2020-11-19 Conversión a escala preparativa de goniautoxinas en neosaxitoxina

Country Status (8)

Country Link
US (2) US10822344B2 (es)
JP (1) JP7110403B2 (es)
CN (1) CN113166164B (es)
CA (1) CA3113727A1 (es)
CL (1) CL2020003015A1 (es)
GB (1) GB2587997B (es)
SG (1) SG11202102830SA (es)
WO (2) WO2020058750A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12018034B2 (en) 2018-09-21 2024-06-25 The Cawthron Institute Trust Board Semisynthetic methods of preparing GTX1,4 and neosaxitoxin
GB2587997B (en) * 2018-09-21 2023-05-10 The Cawthron Inst Trust Board A semisynthetic method of preparing neosaxitoxin
CN112461913B (zh) * 2020-11-06 2022-02-22 华南农业大学 一种提高同分异构体化合物鉴别能力的方法
FR3130842B1 (fr) * 2021-12-22 2025-06-27 CarbonWorks Procede de captation des phytotoxines dans un reacteur biologique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003012699A (ja) * 2001-07-04 2003-01-15 Japan Science & Technology Corp 抗麻酔性貝毒抗体の製法、新規抗体、該抗体を用いるelisa測定キット、該製法による系標識毒標品
JP2006098293A (ja) * 2004-09-30 2006-04-13 Japan Science & Technology Agency 麻痺性貝毒成分の変換方法
CL2009000723A1 (es) * 2009-03-24 2009-06-19 Proteus Sa Metodo de purificacion industrial de ficotoxinas biologicamente activas que comprende proporcionar una cantidad adecuada de una fuente de ficotoxinas como por ejemplo el cultivo de un clon de cianobacterias.
US8957207B2 (en) * 2009-03-24 2015-02-17 Proteus S.A. Methods for producing phycotoxins
JP6422814B2 (ja) * 2015-04-16 2018-11-14 学校法人北里研究所 デカルバモイルサキシトキシン及びその類縁体の製造方法
GB2587997B (en) * 2018-09-21 2023-05-10 The Cawthron Inst Trust Board A semisynthetic method of preparing neosaxitoxin

Also Published As

Publication number Publication date
NZ770197A (en) 2024-04-26
JP7110403B2 (ja) 2022-08-01
GB2587997A (en) 2021-04-14
US20200407367A1 (en) 2020-12-31
US11028094B2 (en) 2021-06-08
CN113166164A (zh) 2021-07-23
CN113166164B (zh) 2024-01-30
US20200255441A1 (en) 2020-08-13
SG11202102830SA (en) 2021-04-29
US10822344B2 (en) 2020-11-03
GB2587997B (en) 2023-05-10
WO2020058949A1 (en) 2020-03-26
WO2020058750A1 (en) 2020-03-26
GB202018189D0 (en) 2021-01-06
CA3113727A1 (en) 2020-03-26
JP2021526539A (ja) 2021-10-07

Similar Documents

Publication Publication Date Title
CL2020003015A1 (es) Conversión a escala preparativa de goniautoxinas en neosaxitoxina
CR20200532A (es) Compuestos de heteroarilo tetracíclicos
BR112022010254A2 (pt) Composto heterocíclico contendo oxigênio representado pela fórmula i, método para preparar o composto heterocíclico contendo oxigênio, composto, composição farmacêutica e uso composto heterocíclico contendo oxigênio
SA522433155B1 (ar) مركبات ثلاثية الحلقة مستبدلة
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MX2020013817A (es) Compuestos de naftiridinona sustituidos utiles como activadores de celulas t.
PH12019502245A1 (en) Compounds that inhibit mcl-1 protein
EA202190137A1 (ru) Нафтиридиноновые соединения для применения в качестве активаторов t-клеток
ZA202203515B (en) Substituted pyridopyrimidinonyl compounds useful as t cell activators
CL2019001077A1 (es) Derivados de 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f] isoquinolina útiles en el tratamiento del cáncer.
JOP20210301A1 (ar) بيرولات ثلاثية الحلقة مكثفة كمُعدِّلات مضاد تريبسين ألفا-1
UY38001A (es) Compuestos que inhiben las proteínas ras mutantes g12c
MX2020002825A (es) Beta-hidroxietilaminas heteroaril sustituidas para su uso en el tratamiento de hiperglucemia.
AR111233A1 (es) Inhibidores de tyk2, usos y métodos para la producción de los mismos
PE20190326A1 (es) Isoquinolin-3-il-carboxamidas y preparacion y uso de las mismas
MY189761A (en) Quinazoline derivatives used to treat hiv
CR20220236A (es) Aminoquinolonas sustituidas como inhibidores de dgk alfa para la activación inmune
PH12017500281B1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
MX379155B (es) Compuestos que inhiben la proteína mcl-1.
CU20200008A7 (es) Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas, métodos para preparar dichos compuestos y composiciones farmacéuticas que los contienen
UY35275A (es) Derivados de aminopirazina
MX2021015056A (es) Compuesto de pirrolopirimidina y uso del mismo.
SG11201901962QA (en) Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof
CU20120137A7 (es) Hidrato del hidrocloruro de agomelatina y preparación de éste
BR112022009563A2 (pt) Compostos de pirrolotriazina atuando como inibidor de mnk